TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Super Synbiotics AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,260
|
1,302
|
1,622 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
3
|
-106
|
175 |
| EBITDA |
1
|
-106
|
175 |
| Total assets |
593
|
579
|
965 |
| Current assets |
588
|
575
|
960 |
| Current liabilities |
203
|
194
|
235 |
| Equity capital |
390
|
385
|
730 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
3
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
65.8%
|
66.5%
|
75.6% |
| Turnover per employee |
1,260
|
434
|
811 |
| Profit as a percentage of turnover |
0.2%
|
-8.1%
|
10.8% |
| Return on assets (ROA) |
0.5%
|
-18.3%
|
18.1% |
| Current ratio |
289.7%
|
296.4%
|
408.5% |
| Return on equity (ROE) |
0.8%
|
-27.5%
|
24.0% |
| Change turnover |
-46
|
-189
|
-133 |
| Change turnover % |
-4%
|
-13%
|
-8% |
| Chg. No. of employees |
-2
|
1
|
0 |
| Chg. No. of employees % |
-67%
|
50%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.